Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dulac Farmaceutici is an Italian pharmaceutical company founded in 1982, specializing in the development and commercialization of nutraceuticals, medical devices, and dermocosmetics. The company is recognized for its high-concentration formulations, particularly its Arnica-based gels and Diosmin-based supplements designed for vascular and musculoskeletal health. Dulac operates primarily in the over-the-counter (OTC) market, providing solutions for hemorrhoids, joint pain, and venous insufficiency. Headquartered in Rivoli, Italy, the company distributes its products through pharmacies and major e-commerce platforms globally. Its business model focuses on combining traditional herbal ingredients with modern pharmaceutical standards to ensure efficacy and safety.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dulac Farmaceutici.